Baxter International (NYSE:BAX) Issues Q4 2024 Earnings Guidance

Baxter International (NYSE:BAX) updated its fourth quarter 2024 earnings guidance on Friday. The company provided earnings per share guidance of 0.770-0.810 for the period, compared to the consensus earnings per share estimate of 0.840. The company issued revenue guidance of -. Baxter International also updated its FY 2024 guidance to 2.900-2.940 EPS.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on Baxter International from $44.00 to $42.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. StockNews.com raised Baxter International from a “hold” rating to a “buy” rating in a research report on Tuesday, October 22nd. Morgan Stanley cut Baxter International from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $39.00 to $30.00 in a research report on Monday, July 15th. The Goldman Sachs Group raised their price objective on shares of Baxter International from $36.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, August 8th. Finally, Citigroup upped their target price on shares of Baxter International from $38.00 to $40.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $41.20.

Baxter International Stock Down 3.9 %

Shares of BAX stock opened at $34.64 on Friday. Baxter International has a one year low of $32.48 and a one year high of $44.01. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.40 and a quick ratio of 0.91. The stock has a fifty day moving average price of $37.39 and a 200 day moving average price of $36.12. The stock has a market cap of $17.67 billion, a P/E ratio of 7.13, a price-to-earnings-growth ratio of 1.22 and a beta of 0.60.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Friday, November 8th. The medical instruments supplier reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.02. The company had revenue of $3.85 billion during the quarter, compared to the consensus estimate of $3.85 billion. Baxter International had a net margin of 16.51% and a return on equity of 18.06%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the firm earned $0.68 EPS. Analysts predict that Baxter International will post 2.96 earnings per share for the current year.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.